Page last updated: 2024-09-03

pramipexole and Cardiac Failure

pramipexole has been researched along with Cardiac Failure in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cauthon, KA; DeBacker, D; Lockett, K1
Brophy, JM; Dell'Aniello, S; Renoux, C; Suissa, S1

Other Studies

3 other study(ies) available for pramipexole and Cardiac Failure

ArticleYear
Pramipexole: heart failure.
    Prescrire international, 2013, Volume: 22, Issue:141

    Topics: Antiparkinson Agents; Benzothiazoles; Heart Failure; Humans; Parkinson Disease; Pramipexole; Restless Legs Syndrome; Risk

2013
The link between non-ergot-derived dopamine agonists and heart failure: how strong is it?
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2015, Volume: 30, Issue:3

    Topics: Benzothiazoles; Dopamine Agonists; Heart Failure; Humans; Indoles; Pramipexole

2015
Dopamine agonist use and the risk of heart failure.
    Pharmacoepidemiology and drug safety, 2012, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Case-Control Studies; Databases, Factual; Dopamine Agonists; Ergolines; Female; Heart Failure; Humans; Incidence; Logistic Models; Male; Middle Aged; Pramipexole; Risk; United Kingdom

2012